// App-Quantinova.ai

: Bevacizumab in first-line therapy in lung metastases of colorectal cancer: An ARCAD pooled analysis.

Researchers

Presenter

  • Einat S Shmueli

Principal Investigators

  • Morteza Raeisi

  • Benoist Chibaudel

  • Herbert Hurwitz

  • Leonard B. Saltz

  • Fairooz F. Kabbinavar

  • Niall C. Tebbutt

  • Axel Grothey

  • Richard Adams

  • John Raymond Zalcberg

  • Takayuki Yoshino

  • Jean-Baptiste Bachet

  • Romain Cohen

  • Lama Sharara

  • Thierry Andre

  • Qian Shi

  • Aimery De Gramont

Medical Centers

  • Duke Cancer Institute, Duke University Medical Center, Durham, NC

  • Sorbonne University, Hepatogastroenterology and Digestive Oncology Department, Pitié Salpêtrière Hospital, APHP, Paris, France

  • Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France

  • Fondation A.R.CA.D.-Aide et Recherche en Cancérologie Digestive, Levallois-Perret, France

  • Fondation A.R.CA.D.-Aide et Recherche en Cancérologie Digestive, Levallois-Perret, France

  • Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, Kashiwa, Japan

  • Hopital Franco-Britannique-Fondation Cognacq-Jay, Levallois-Perret, France

  • Deakin University, Melbourne, Australia

  • Mayo Clinic, Rochester, MN

  • Kite Pharma, Los Angeles, CA

  • Department of Radiation Oncology, Olivia Newton John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Australia

  • West Cancer Center, Germantown, TN

  • Sorbonne Université, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Cancer Center, The Chaim Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Ramat Gan, Israel

  • Cardiff University and Velindre Cancer Centre, Cardiff, United Kingdom

Locations

  • United Kingdom

  • Australia

  • United States

  • Israel

  • Japan

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

  • Oxaliplatin

  • Irinotecan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved